LIPO OTC
Lipella Pharmaceuticals Inc.
1W: -0.0%
1M: +0.0%
3M: -99.4%
YTD: -99.7%
1Y: -99.9%
3Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000199999995-0.6407
Volume594
Avg Volume54,205
Beta1.57
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJonathan Kaufman
Employees7
SectorHealthcare
IndustryBiotechnology
IPO Date2022-12-19
Websitelipella.com
7800 Susquehanna St.
Pittsburgh, PA 15208
US
Pittsburgh, PA 15208
US
412-894-1853
About Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the creation of novel therapies. The company achieves this by repurposing and optimizing the active ingredients found in established generic drugs, tailoring these reformulations for diverse medical applications. Its lead candidate, LP-10, a tacrolimus formulation, is presently in Phase IIa clinical studies, targeting radiation-induced hemorrhagic cystitis. Additionally, LP-310, another tacrolimus-derived compound, is under development for the management of oral lichen planus. Founded in 2005, the company maintains its headquarters in Pittsburgh, Pennsylvania.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kaufman Jonathan H | J-Other | 536,959 | $1.00 | 2025-04-03 |
| Kaufman Jonathan H | J-Other | 4,060 | $1.00 | 2025-04-03 |
| Kaufman Jonathan H | J-Other | 10,326 | $1.00 | 2025-03-13 |
| Kaufman Jonathan H | J-Other | 4,060 | $1.00 | 2025-03-13 |
| Kaufman Jonathan H | J-Other | 84,700 | $1.00 | 2025-03-10 |